The global Benign Prostatic Hyperplasia Surgical Treatment Market size was valued at USD 2,042.94 million in 2024 and is expected to grow at a CAGR of 5.3% The aging male population's growing need for ...

The Five-item Frailty Index (5i-FI) is a tool used by physicians to predict surgical risk and postoperative complications after a procedure. Researchers from Brigham and Women's Hospital, a founding ...

At University of Utah Health, our urologists specialize in helping men achieve better health with top-notch specialty care and the latest advances in treatment and therapies. We provide care for a ...

The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

Astute Analytica released an extensive market assessment report titled “Global Benign Prostatic Hyperplasia Surgical Treatment Market: Trends, Industry Competition Analysis, Revenue, and Forecast to ...